133 related articles for article (PubMed ID: 17137581)
1. Differential functions of tissue factor in the trans-activation of cellular signalling pathways.
Ettelaie C; Li C; Collier ME; Pradier A; Frentzou GA; Wood CG; Chetter IC; McCollum PT; Bruckdorfer KR; James NJ
Atherosclerosis; 2007 Sep; 194(1):88-101. PubMed ID: 17137581
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
[TBL] [Abstract][Full Text] [Related]
4. Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
Jiang R; Wang NP; Tanaka KA; Levy JH; Guyton RA; Zhao ZQ; Vinten-Johansen J
J Surg Res; 2011 Aug; 169(2):319-27. PubMed ID: 20451919
[TBL] [Abstract][Full Text] [Related]
5. Exclusion of known protease-activated receptors in factor VIIa-induced signal transduction.
Petersen LC; Thastrup O; Hagel G; Sørensen BB; Freskgård PO; Rao LV; Ezban M
Thromb Haemost; 2000 Apr; 83(4):571-6. PubMed ID: 10780319
[TBL] [Abstract][Full Text] [Related]
6. CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway.
Chen Y; Wang J; Yao Y; Yuan W; Kong M; Lin Y; Geng D; Nie R
FEBS Lett; 2009 Sep; 583(17):2811-8. PubMed ID: 19631649
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
8. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
[TBL] [Abstract][Full Text] [Related]
10. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
11. Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation.
Collier ME; Ettelaie C
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1810-7. PubMed ID: 20616308
[TBL] [Abstract][Full Text] [Related]
12. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
16. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
17. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
Edgington TS; Mackman N; Fan ST; Ruf W
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
Sevinsky JR; Rao LV; Ruf W
J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of plasma TNF-α are associated with microvascular endothelial dysfunction in patients with sepsis through activating the NF-κB and p38 mitogen-activated protein kinase in endothelial cells.
Liang Y; Li X; Zhang X; Li Z; Wang L; Sun Y; Liu Z; Ma X
Shock; 2014 Apr; 41(4):275-81. PubMed ID: 24430552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
